Does SITAGLIPTIN Cause Product quality issue? 91 Reports in FDA Database

Q: Does SITAGLIPTIN cause Product quality issue?

91 reports of Product quality issue have been filed with the FDA for SITAGLIPTIN, representing 0.5% of all SITAGLIPTIN adverse event reports.

Q: How dangerous is Product quality issue from SITAGLIPTIN?

Of 91 reports, 1 (1.1%) resulted in death and 9 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Product quality issue have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.5% of all adverse event reports for SITAGLIPTIN.

Reports of Product quality issue with SITAGLIPTIN

0.5%

of all SITAGLIPTIN reports

Deaths

Hospitalizations

How Dangerous Is Product quality issue From SITAGLIPTIN?

Of the 91 reports, 1 (1.1%) resulted in death, 9 (9.9%) required hospitalization, and 2 (2.2%) were considered life-threatening.

Is Product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 91 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922) 503 Service Unavailable

Service Unavailable

The server is temporarily unable to service your request due to maintenance downtime or capacity problems. Please try again later.

Additionally, a 503 Service Unavailable error was encountered while trying to use an ErrorDocument to handle the request.